Interest in, willingness-to-pay for and willingness-to-recommend genetic testing for prostate cancer among affected men after radical prostatectomy
- 135 Downloads
Knowledge about interest in genetic testing and willingness-to-pay for a genetic test among men affected from prostate cancer (PCa) is limited. This study aimed to gain insight into men’s attitudes in genetic testing for PCa. 4699 men with PCa from the German multicenter prospective database “Familial Prostate Cancer” were included. Interest in, Willingness-to-pay for and Willingness-to-recommend a genetic test for PCa were quantified. Associations with several sociodemographic and psychosocial variables were evaluated by logistic regression. 76.8% of the affected men with a median follow-up of 12.9 years were interested in a genetic test for PCa. Newly identified variables significantly associated with interest were having sons (OR 1.66, p < 0.001) and a high perceived severity of the PCa (OR 1.40, p < 0.001). 19% of men were willing to pay more than 500 € for a genetic test. Men with higher education, men with a better self-reported economic situation and men with a lethal PCa in their family were more likely to be willing to pay a larger sum for a test. 84.9% of men were willing to recommend a test to their relatives. Interest in genetic testing for PCa among affected men was generally high with most men willing to recommend a test to their relatives. Various characteristics associated with interest and willingness-to-pay larger sums for genetic testing were uncovered and need to be addressed when designing both future educational material and genetic tests for PCa.
KeywordsProstate cancer Genetic testing Genomic testing Interest Family history
The authors thank all the patients for their participation in the study.
This study was designed by KH. Statistical analysis was performed by KS. MM drafted the manuscript. FT and AD participated in the revising of the manuscript. All authors read and approved the final manuscript.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
- 1.Bericht zum Krebsgeschehen in Deutschland (2016) http://www.krebsdaten.de/Krebs/DE/Content/Publikationen/Krebsgeschehen/Epidemiologie/Kapitel2_Epidemiologie.pdf?__blob=publicationFile. Accessed 20 Apr 2017
- 2.Cancer Stat Facts: Prostate Cancer (2016) https://seer.cancer.gov/statfacts/html/prost.html. Accessed 20 Apr 2017
- 3.Prostate Cancer: Statistics (2017) http://www.cancer.net/cancer-types/prostate-cancer/statistics. Accessed 30 July 2017
- 10.Xu J, Lange EM, Lu L, Zheng SL, Wang Z, Thibodeau SN, Cannon-Albright LA, Teerlink CC, Camp NJ, Johnson AM, Zuhlke KA, Stanford JL, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Maier C, Luedeke M, Vogel W, Schleutker J, Wahlfors T, Tammela T, Schaid D, McDonnell SK, DeRycke MS, Cancel-Tassin G, Cussenot O, Wiklund F, Gronberg H, Eeles R, Easton D, Kote-Jarai Z, Whittemore AS, Hsieh CL, Giles GG, Hopper JL, Severi G, Catalona WJ, Mandal D, Ledet E, Foulkes WD, Hamel N, Mahle L, Moller P, Powell I, Bailey-Wilson JE, Carpten JD, Seminara D, Cooney KA, Isaacs WB, International Consortium for Prostate Cancer G (2013) HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG). Hum Genet 132(1):5–14. https://doi.org/10.1007/s00439-012-1229-4 CrossRefPubMedGoogle Scholar
- 13.Lüdeke JX M, Zheng SL, Sonntag P, Schulwitz H, Rinckleb AE, Schrader AJ, Schrader M, Vogel W, Hoegel J, Herkommer K, Maier C (2013) Prevalence and clinical features of HOXB13 mutation carriers in German prostate cancer patient. Der Urologe Suppl 1 (2013):118Google Scholar
- 14.Gallagher DJ, Gaudet MM, Pal P, Kirchhoff T, Balistreri L, Vora K, Bhatia J, Stadler Z, Fine SW, Reuter V, Zelefsky M, Morris MJ, Scher HI, Klein RJ, Norton L, Eastham JA, Scardino PT, Robson ME, Offit K (2010) Germline BRCA mutations denote a clinicopathologic subset of prostate cancer. Clin Cancer Res 16(7):2115–2121. https://doi.org/10.1158/1078-0432.CCR-09-2871 CrossRefPubMedPubMedCentralGoogle Scholar
- 19.Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, Adami HO, Hsu FC, Zhu Y, Balter K, Kader AK, Turner AR, Liu W, Bleecker ER, Meyers DA, Duggan D, Carpten JD, Chang BL, Isaacs WB, Xu J, Gronberg H (2008) Cumulative association of five genetic variants with prostate cancer. N Engl J Med 358(9):910–919. https://doi.org/10.1056/NEJMoa075819 CrossRefPubMedGoogle Scholar
- 24.Harris JN, Bowen DJ, Kuniyuki A, McIntosh L, FitzGerald LM, Ostrander EA, Stanford JL (2009) Interest in genetic testing among affected men from hereditary prostate cancer families and their unaffected male relatives. Genet Med 11(5):344–355. https://doi.org/10.1097/GIM.0b013e31819b2425 CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Bruno M, Tommasi S, Stea B, Quaranta M, Schittulli F, Mastropasqua A, Distante A, Di Paola L, Paradiso A (2004) Awareness of breast cancer genetics and interest in predictive genetic testing: a survey of a southern Italian population. Ann Oncol 15(Suppl 1):I48–I54. https://doi.org/10.1093/annonc/mdh658 CrossRefPubMedGoogle Scholar
- 28.Paiss T, Bock B, Gschwend JE, Heinz H, Vogel W, Kron M, Hautmann RE, Herkommer K (2003) Familial versus sporadic prostate cancer in the German population. Clinical and pathological characteristics in patients after radical prostatectomy. Urologe A 42(7):946–953. https://doi.org/10.1007/s00120-003-0296-5 CrossRefPubMedGoogle Scholar
- 31.Lowe B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, Schneider A, Brahler E (2010) A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord 122(1–2):86–95. https://doi.org/10.1016/j.jad.2009.06.019 CrossRefPubMedPubMedCentralGoogle Scholar
- 32.Team RC (2017) R: a language and environment for statistical computing. R Foundation for Statistical Computing, ViennaGoogle Scholar
- 37.Petrucelli N, Daly MB, Pal T (1993) BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer. In: Pagon RA, Adam MP, Ardinger HH et al (eds) GeneReviews(R). Seattle (WA)Google Scholar
- 42.Day JC, Newburger EC (2002) The Big Payoff: Educational Attainment and Synthetic Estimates of Work-Life Earnings. Special Studies. Current Population ReportsGoogle Scholar
- 43.NCI (2015) BRCA1 and BRCA2: Cancer Risk and Genetic Testing. National Cancer Institue (NCI) at the National Institutes of HealthGoogle Scholar